205
Views
15
CrossRef citations to date
0
Altmetric
Original Research

Estimation of the Clinical and Economic Impact of an Improvement in Adherence Based on the Use of Once-Daily Single-Inhaler Triple Therapy in Patients with COPD

ORCID Icon, ORCID Icon, ORCID Icon, , &
Pages 1643-1654 | Published online: 10 Jul 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (9)

Miguel Turégano-Yedro, Eva Trillo-Calvo, Fernando Navarro i Ros, José David Maya-Viejo, Cruz González Villaescusa, Jose Maria Echave Sustaeta, Esperanza Doña & Bernardino Alcázar Navarrete. (2023) Inhaler Adherence in COPD: A Crucial Step Towards the Correct Treatment. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 2887-2893.
Read now
Marc Miravitlles, Sudeep Acharya, Bhumika Aggarwal, Frederico LA Fernandes, Jorge Dreyse, José R Jardim, Siwasak Juthong, Gur Levy & Martin Sivori. (2023) Clinical Concepts for Triple Therapy Use in Patients with COPD: A Delphi Consensus. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 1853-1866.
Read now
Michael Bogart, Guillaume Germain, François Laliberté, Dominique Lejeune & Mei Sheng Duh. (2023) Real-World Treatment Patterns and Switching Following Moderate/Severe Chronic Obstructive Pulmonary Disease Exacerbation in Patients with Commercial or Medicare Insurance in the United States. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 1575-1586.
Read now
Hongxia Wu, Hui Zhang, Xin Li & Qian Zhao. (2023) Effects of medication adherence on disease activity in chronic obstructive pulmonary disease: a systematic review and meta-analysis. Psychology, Health & Medicine 28:7, pages 1656-1670.
Read now
Leah B Sansbury, David A Lipson, Chanchal Bains, Glenn A Anley, Kieran J Rothnie & Afisi S Ismaila. (2022) Disease Burden and Healthcare Utilization Among Patients with Chronic Obstructive Pulmonary Disease (COPD) in England. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 415-426.
Read now
Rezwanul Hasan Rana, Khorshed Alam, Syed Afroz Keramat & Jeff Gow. (2022) Cost-effectiveness of single-inhaler triple therapy for patients with severe COPD: a systematic literature review. Expert Review of Respiratory Medicine 16:10, pages 1067-1084.
Read now
Mario Cazzola, Paola Rogliani, Luigino Calzetta, Josuel Ora & Maria Gabriella Matera. (2022) A single inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol for the treatment of COPD. Expert Review of Clinical Pharmacology 15:3, pages 269-283.
Read now
Bernardino Alcázar-Navarrete, Francisco García-Rio, Guadalupe Sánchez, Esther Mariscal, Andrea García, Maribel Cuesta, Estefany Uría & Marc Miravitlles. (2021) Burden of Disease Among Exacerbating Patients with COPD Treated with Triple Therapy in Spain. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 2149-2161.
Read now
Gerard J Criner, Therese Cole, Kristen A Hahn, Kari Kastango, James Eudicone & Ileen Gilbert. (2021) The Impact of Budesonide/Formoterol pMDI Medication Reminders on Adherence in Chronic Obstructive Pulmonary Disease (COPD) Patients: Results of a Randomized, Phase 4, Clinical Study. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 563-577.
Read now

Articles from other publishers (6)

William W. Busse, Carl B. Abbott, Guillaume Germain, François Laliberté, Sean D. MacKnight, Young Jung, Mei Sheng Duh & Carlyne M. Averell. (2022) Adherence and Persistence to Single-Inhaler Versus Multiple-Inhaler Triple Therapy for Asthma Management. The Journal of Allergy and Clinical Immunology: In Practice 10:11, pages 2904-2913.e6.
Crossref
James Hall, Alice Margaret Turner, Janine Dretzke, David Moore & Sue Jowett. (2022) Cost-effectiveness of domiciliary non-invasive ventilation in patients with chronic obstructive pulmonary disease. Thorax 77:10, pages 976-986.
Crossref
David Mannino, Michael Bogart, Benjamin Wu, Guillaume Germain, François Laliberté, Sean D. MacKnight, Young Jung, Marjorie Stiegler & Mei Sheng Duh. (2022) Adherence and persistence to once-daily single-inhaler versus multiple-inhaler triple therapy among patients with chronic obstructive pulmonary disease in the USA: A real-world study. Respiratory Medicine 197, pages 106807.
Crossref
Miriam Barrecheguren, Monica Monteagudo, Marc Miravitlles, Xavier Flor, Alexa Núñez, Jeisson Osorio, Xavier Muñoz & Iñigo Ojanguren. (2022) Characteristics and treatment patterns of patients with asthma on multiple-inhaler triple therapy in Spain. npj Primary Care Respiratory Medicine 32:1.
Crossref
Chih-Cheng Lai, Chao-Hsien Chen, Kuang-Hung Chen, Cheng-Yi Wang, Tsan-Ming Huang, Ya-Hui Wang & Hao-Chien Wang. (2022) The Impact of 52-Week Single Inhaler Device Triple Therapy versus Dual Therapy on the Mortality of COPD Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Life 12:2, pages 173.
Crossref
Huanyu Long, Hongxuan Xu, Jean-Paul Janssens & Yanfei Guo. (2021) Single-inhaler triple vs single-inhaler dual therapy in patients with chronic obstructive pulmonary disease: a meta-analysis of randomized control trials. Respiratory Research 22:1.
Crossref